Concepedia

Author

Carmen Barnes

Alnylam Pharmaceuticals (United States)

Also Known As

C. Barnes, C.Ryan Barnes, Carmen Barnes

25

Publications

1.8K

Citations

10

H-Index

38

Concepts

All Affiliations

Alnylam Pharmaceuticals (United States)Massachusetts Institute of TechnologyHarvard UniversityHarvard–MIT Division of Health Sciences and TechnologySkolkovo Institute of Science and Technology
CB

About

Carmen Barnes is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, vascular biology, and gene expression.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

128

2

Engineering

2

2

577

3

Natural Sciences

1

1

11

4

Biochemistry

1

1

11

5

Biomedical Engineering

1

1

567

Carmen Barnes

×

10

Publications

1.8K

Citations

10

H-Index

YearCitations

In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight

James E. Dahlman, Carmen Barnes, Omar F. Khan,

Nature Nanotechnology

2014

567

Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Yizhou Dong, Kevin T. Love, J. Robert Dorkin,

Proceedings of the National Academy of Sciences

2014

470

FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA Expression

Pei‐Yu Chen, Lingfeng Qin, Carmen Barnes,

Cell Reports

2012

294

Microbial iron transport via a siderophore shuttle: A membrane ion transport paradigm

Alain Stintzi, Carmen Barnes, Jide Xu,

Proceedings of the National Academy of Sciences

2000

254

Transforming Growth Factor-β Promotes Inactivation of Extracellular Thyroid Hormones via Transcriptional Stimulation of Type 3 Iodothyronine Deiodinase

Stephen A. Huang, Michelle A. Mulcahey, Alessandra Crescenzi,

Molecular Endocrinology

2005

71

Adenosine modulation of tumor necrosis factor-α-induced neutrophil activation

Carmen Barnes, Gerald L. Mandell, Holliday T. Carper,

Biochemical Pharmacology

1995

36

Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance

Ida Aronchik, Yumin Dai, Matt Labenski,

Molecular Cancer Research

2018

35

Sucrose octasulfate regulates fibroblast growth factor‐2 binding, transport, and activity: Potential for regulation of tumor growth

Michael Fannon, Kimberly Forsten‐Williams, Matthew A. Nugent,

Journal of Cellular Physiology

2007

11

In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight

James E. Dahlman, Carmen Barnes, Omar F. Khan,

DSpace@MIT (Massachusetts Institute of Technology)

2014

11

RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver

Hao Yin, Roman L. Bogorad, Carmen Barnes,

Journal of Hepatology

2015

10

Page 1